Início › Câncer de Próstata › Montana
Ensaios clínicos de Câncer de Próstata em Montana
17 estudos para Câncer de Próstata estão buscando participantes em locais em Montana.
Cidades em Montana
Texto oficial do estudo (Inglês)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Saint Vincent Frontier Cancer Center, Billings
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
- e mais 1
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT07200830Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e mais 7
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Billings Clinic Cancer Center, Billings
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e mais 3
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06136650A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- St. Vincent Frontier Cancer Center-Research ( Site 0037), Billings
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Billings Clinic Cancer Center, Billings
- Benefis Sletten Cancer Institute, Great Falls
- Hi-Line Sletten Cancer Center, Havre
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- Benefis Sletten Cancer Institute, Great Falls
- e mais 5
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e mais 7
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- Billings Clinic Cancer Center, Billings
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 14 de abr. de 2026 · NCT06235697Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
- University of Montana, Missoula
RecrutandoFase 2
Idades de 18 a 89 · Todos os sexos · Atualizado em 5 de fev. de 2026 · NCT07001241Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Deaconess Hospital, Bozeman
- e mais 4
RecrutandoFase 2
Idades 18 e acima · Homens · Atualizado em 29 de jan. de 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 22 de jan. de 2026 · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Billings Clinic Cancer Center, Billings
- Bozeman Deaconess Hospital, Bozeman
- Saint James Community Hospital and Cancer Treatment Center, Butte
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Homens · Atualizado em 11 de set. de 2025 · NCT03678025Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.